Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H20N2O.ClH |
| Molecular Weight | 268.782 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)C1=CC=C(C)C=C1OCC2=NCCN2
InChI
InChIKey=DKIDQLUKAZZLAR-UHFFFAOYSA-N
InChI=1S/C14H20N2O.ClH/c1-10(2)12-5-4-11(3)8-13(12)17-9-14-15-6-7-16-14;/h4-5,8,10H,6-7,9H2,1-3H3,(H,15,16);1H
| Molecular Formula | C14H20N2O |
| Molecular Weight | 232.3214 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.drugbank.ca/drugs/DB08803Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/21796997 | https://www.ncbi.nlm.nih.gov/pubmed/2481638 | https://www.drugs.com/international/tymazoline.html
Sources: https://www.drugbank.ca/drugs/DB08803
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/21796997 | https://www.ncbi.nlm.nih.gov/pubmed/2481638 | https://www.drugs.com/international/tymazoline.html
Tymazoline (trade name Thymazen in Poland) is a nasal decongestant that can be used to treat rhinitis and nasal obstruction. Tymazoline is a drug with antihistaminic and sympathomimetic properties. It locally reduces swelling, inflammation and mucosal secretions of the nasal passages. Thymazen causes vasoconstriction of the nasal mucosa, reducing congestion and thus the swelling of the mucosa. Also reduces the secretions from the nose. Thymazen acts on alpha-adrenergic receptors, which reduces local inflammation of the nasal mucosa especially if their cause is an allergy.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL231 Sources: Acta Poloniae Pharmaceutica (1960), 17, 349-53. |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.drugbank.ca/drugs/DB08803 |
Primary | Thymazen Approved UseUnknown |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:00:52 GMT 2025
by
admin
on
Mon Mar 31 22:00:52 GMT 2025
|
| Record UNII |
06223H196A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
06223H196A
Created by
admin on Mon Mar 31 22:00:52 GMT 2025 , Edited by admin on Mon Mar 31 22:00:52 GMT 2025
|
PRIMARY | |||
|
34153
Created by
admin on Mon Mar 31 22:00:52 GMT 2025 , Edited by admin on Mon Mar 31 22:00:52 GMT 2025
|
PRIMARY | |||
|
248-854-5
Created by
admin on Mon Mar 31 22:00:52 GMT 2025 , Edited by admin on Mon Mar 31 22:00:52 GMT 2025
|
PRIMARY | |||
|
28120-03-8
Created by
admin on Mon Mar 31 22:00:52 GMT 2025 , Edited by admin on Mon Mar 31 22:00:52 GMT 2025
|
PRIMARY | |||
|
SUB15641MIG
Created by
admin on Mon Mar 31 22:00:52 GMT 2025 , Edited by admin on Mon Mar 31 22:00:52 GMT 2025
|
PRIMARY | |||
|
100000077288
Created by
admin on Mon Mar 31 22:00:52 GMT 2025 , Edited by admin on Mon Mar 31 22:00:52 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |